Published in Nat Nanotechnol on December 01, 2012
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev (2013) 3.44
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat Nanotechnol (2014) 2.24
Assessing the efficacy of nano- and micro-sized magnetic particles as contrast agents for MRI cell tracking. PLoS One (2014) 1.54
Quantification of the cellular dose and characterization of nanoparticle transport during in vitro testing. Part Fibre Toxicol (2016) 1.38
A holistic approach to targeting disease with polymeric nanoparticles. Nat Rev Drug Discov (2015) 1.31
An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol (2014) 1.21
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun (2013) 1.20
Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface (2013) 1.13
New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface (2013) 1.09
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev (2015) 1.08
Fabrication of corona-free nanoparticles with tunable hydrophobicity. ACS Nano (2014) 1.07
Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells. ACS Nano (2013) 1.07
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol (2016) 1.01
Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci (2014) 0.99
Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer (2016) 0.99
A general mechanism for intracellular toxicity of metal-containing nanoparticles. Nanoscale (2014) 0.98
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. J Biomed Semantics (2015) 0.97
Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability. Part Fibre Toxicol (2014) 0.97
Current state of laser synthesis of metal and alloy nanoparticles as ligand-free reference materials for nano-toxicological assays. Beilstein J Nanotechnol (2014) 0.96
Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. Front Chem (2014) 0.95
Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine (2013) 0.95
Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett (2013) 0.94
The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Sci Rep (2015) 0.93
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92
Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci (2013) 0.91
25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine. Adv Mater (2013) 0.90
The effects of nanomaterials as endocrine disruptors. Int J Mol Sci (2013) 0.90
In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far? Beilstein J Nanotechnol (2014) 0.90
The nano-plasma interface: Implications of the protein corona. Colloids Surf B Biointerfaces (2014) 0.90
Entering the era of nanoscience: time to be so small. J Biomed Nanotechnol (2013) 0.89
Nanostructures: a platform for brain repair and augmentation. Front Syst Neurosci (2014) 0.89
Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc (2014) 0.89
Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J Phys Chem B (2014) 0.89
Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Part Fibre Toxicol (2014) 0.88
Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells. Adv Funct Mater (2015) 0.88
Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties. Int J Nanomedicine (2014) 0.87
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
Intestinal absorption and biological effects of orally administered amorphous silica particles. Nanoscale Res Lett (2014) 0.87
Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models. Nanoscale Res Lett (2015) 0.87
Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis. Crit Rev Ther Drug Carrier Syst (2015) 0.86
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2015) 0.86
Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications. Toxicol Appl Pharmacol (2016) 0.86
Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf B Biointerfaces (2013) 0.86
High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles. PLoS One (2014) 0.86
Cell type-dependent changes in CdSe/ZnS quantum dot uptake and toxic endpoints. Toxicol Sci (2015) 0.86
When nanoparticles meet biofilms-interactions guiding the environmental fate and accumulation of nanoparticles. Front Microbiol (2015) 0.86
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. Adv Drug Deliv Rev (2015) 0.86
Inorganic Nanoparticles for Therapeutic Delivery: Trials, Tribulations and Promise. Curr Opin Colloid Interface Sci (2014) 0.85
Gold nanoparticles stabilized with MPEG-grafted poly(l-lysine): in vitro and in vivo evaluation of a potential theranostic agent. Bioconjug Chem (2014) 0.85
Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations. PLoS One (2013) 0.85
Nanoparticle Uptake: The Phagocyte Problem. Nano Today (2015) 0.84
Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona. ACS Nano (2013) 0.84
Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnology (2015) 0.84
Rapid endosomal escape of prickly nanodiamonds: implications for gene delivery. Sci Rep (2015) 0.84
Molecular modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells. Adv Drug Deliv Rev (2013) 0.84
Role of Albumin in the Formation and Stabilization of Nanoparticle Aggregates in Serum Studied by Continuous Photon Correlation Spectroscopy and Multiscale Computer Simulations. J Phys Chem C Nanomater Interfaces (2014) 0.83
Safety of Nanoparticles in Medicine. Curr Drug Targets (2015) 0.83
Lactose as a "Trojan horse" for quantum dot cell transport. Angew Chem Int Ed Engl (2013) 0.83
Nanoparticle interactions with live cells: Quantitative fluorescence microscopy of nanoparticle size effects. Beilstein J Nanotechnol (2014) 0.83
The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles. Int J Nanomedicine (2015) 0.83
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine (2014) 0.83
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles. Environ Sci Nano (2015) 0.83
Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging. Small (2016) 0.82
Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci Rep (2016) 0.82
The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells. Int J Environ Res Public Health (2015) 0.82
Protein corona - from molecular adsorption to physiological complexity. Beilstein J Nanotechnol (2015) 0.82
A hyperspectral and toxicological analysis of protein corona impact on silver nanoparticle properties, intracellular modifications, and macrophage activation. Int J Nanomedicine (2015) 0.81
Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. Nanomedicine (2014) 0.81
The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates. Small (2016) 0.81
Biological interactions of carbon-based nanomaterials: From coronation to degradation. Nanomedicine (2015) 0.81
Protein corona: Opportunities and challenges. Int J Biochem Cell Biol (2016) 0.81
Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett (2015) 0.81
Surface chemistry and serum type both determine the nanoparticle-protein corona. J Proteomics (2015) 0.81
Gold nanoparticles for cancer radiotherapy: a review. Cancer Nanotechnol (2016) 0.81
Enabling non-invasive assessment of an engineered endothelium on ePTFE vascular grafts without increasing oxidative stress. Biomaterials (2015) 0.81
Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview. Stem Cells Int (2015) 0.80
The Internal Dynamics of Fibrinogen and Its Implications for Coagulation and Adsorption. PLoS Comput Biol (2015) 0.80
Stealth nanotubes: strategies of shielding carbon nanotubes to evade opsonization and improve biodistribution. Int J Nanomedicine (2014) 0.80
An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin core. Nat Nanotechnol (2015) 0.80
The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles. Beilstein J Nanotechnol (2014) 0.80
Inhalation of silver nanomaterials--seeing the risks. Int J Mol Sci (2014) 0.80
Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol (2016) 0.80
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem (2014) 0.80
Bridging the divide between human and environmental nanotoxicology. Nat Nanotechnol (2015) 0.79
Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.79
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities. Adv Drug Deliv Rev (2015) 0.79
Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model. Nanoscale (2013) 0.79
The cell-type specific uptake of polymer-coated or micelle-embedded QDs and SPIOs does not provoke an acute pro-inflammatory response in the liver. Beilstein J Nanotechnol (2014) 0.79
Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles. J Mater Chem B Mater Biol Med (2014) 0.79
From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system. Toxicol Sci (2014) 0.79
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model. Alzheimers Res Ther (2013) 0.78
Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: multiscale theoretical simulations. PLoS Comput Biol (2013) 0.78
Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. ACS Nano (2014) 0.78
Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress. Nanotoxicology (2014) 0.78
Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development. Beilstein J Nanotechnol (2014) 0.78
Intracellular signal modulation by nanomaterials. Adv Exp Med Biol (2014) 0.78
Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects. Int J Nanomedicine (2014) 0.78
The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Mechanisms of endocytosis. Annu Rev Biochem (2009) 10.07
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J (2004) 6.90
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater (2008) 4.81
Virus entry by endocytosis. Annu Rev Biochem (2010) 3.74
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev (2003) 3.19
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol (2010) 2.85
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials (2004) 2.80
Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A (2011) 2.66
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev (2011) 2.41
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
Time evolution of the nanoparticle protein corona. ACS Nano (2010) 2.30
Stability and aggregation of metal oxide nanoparticles in natural aqueous matrices. Environ Sci Technol (2010) 2.21
Materials engineering for immunomodulation. Nature (2009) 2.18
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target (2002) 2.02
Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir (2005) 1.97
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Transformations of nanomaterials in the environment. Environ Sci Technol (2012) 1.86
A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol (2009) 1.85
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev (2009) 1.83
Complement activation and protein adsorption by carbon nanotubes. Mol Immunol (2005) 1.81
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci (2007) 1.77
Interaction of gold nanoparticles with common human blood proteins. ACS Nano (2010) 1.74
Higher surface energy of free nanoparticles. Phys Rev Lett (2003) 1.73
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med (2010) 1.71
Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano (2010) 1.69
An index for characterization of nanomaterials in biological systems. Nat Nanotechnol (2010) 1.69
The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials (2008) 1.68
Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano (2011) 1.66
Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J Am Chem Soc (2010) 1.65
Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano (2011) 1.53
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc (2006) 1.47
Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol Biosci (2008) 1.44
Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology (2009) 1.43
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano (2010) 1.41
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. Langmuir (2011) 1.26
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. ACS Nano (2011) 1.24
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv (2011) 1.23
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology (2011) 1.19
Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS One (2009) 1.16
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv Drug Deliv Rev (2011) 1.15
Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques. Anal Chem (2011) 1.13
Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J Am Chem Soc (2010) 1.12
Nanoparticles: molecular targets and cell signalling. Arch Toxicol (2010) 1.09
Regulation of enzyme activity through interactions with nanoparticles. Int J Mol Sci (2009) 1.09
The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology (2010) 1.08
Effect of gold nanoparticle morphology on adsorbed protein structure and function. Biomaterials (2011) 1.08
Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano (2012) 1.08
Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics (2011) 1.06
Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano (2009) 1.05
Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomedicine (Lond) (2008) 1.05
Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm (2010) 1.04
Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano (2012) 1.04
Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev (2011) 1.01
Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther (2010) 1.00
Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner. Nano Lett (2011) 1.00
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis (2007) 1.00
Ordering surfaces on the nanoscale: implications for protein adsorption. J Am Chem Soc (2011) 0.99
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano (2012) 0.98
Effect of the surface curvature on the secondary structure of peptides adsorbed on nanoparticles. J Am Chem Soc (2007) 0.98
Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir (2011) 0.96
Synthetic polymer nanoparticle-polysaccharide interactions: a systematic study. J Am Chem Soc (2012) 0.96
Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) (2012) 0.95
A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. J Am Chem Soc (2012) 0.93
Cellular binding of nanoparticles in the presence of serum proteins. Chem Commun (Camb) (2010) 0.92
Dispersion and toxicity of selected manufactured nanomaterials in natural river water samples: effects of water chemical composition. Environ Sci Technol (2009) 0.91
Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. Anal Biochem (2011) 0.90
Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. Langmuir (2011) 0.89
The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm (2010) 0.89
Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms. ACS Nano (2011) 0.89
A facile nanoparticle immunoassay for cancer biomarker discovery. J Nanobiotechnology (2011) 0.86
Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere (2010) 0.85
Analytical strategies for detecting nanoparticle-protein interactions. Analyst (2010) 0.85
Quantifying the nanomachinery of the nanoparticle-biomolecule interface. Small (2011) 0.84
Interaction between nanoparticles and cytokine proteins: impact on protein and particle functionality. Nanotechnology (2010) 0.81
An integrated approach to the study of the interaction between proteins and nanoparticles. Langmuir (2010) 0.81
Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: comparison of sample application and isoelectric focusing techniques. Electrophoresis (2000) 0.80
Interaction strength between proteins and polyelectrolyte brushes: a small angle X-ray scattering study. Phys Chem Chem Phys (2011) 0.78
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol (2011) 1.09
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Novel method to prepare morphologically rich polymeric surfaces for biomedical applications via phase separation and arrest of microgel particles. J Phys Chem B (2006) 1.03
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.03
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc Natl Acad Sci U S A (2009) 1.01
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effect. Proc Natl Acad Sci U S A (2003) 1.00
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano (2012) 0.98
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology (2011) 0.97
A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale (2011) 0.96
DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra. Biochim Biophys Acta (2004) 0.95
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol (2006) 0.93
Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale (2014) 0.93
Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology (2010) 0.93
Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology (2010) 0.91
Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One (2011) 0.90
Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacol Ther (2004) 0.89
Low dose of amino-modified nanoparticles induces cell cycle arrest. ACS Nano (2013) 0.87
Transferrin coated nanoparticles: study of the bionano interface in human plasma. PLoS One (2012) 0.86
Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. J Nanobiotechnology (2012) 0.86
Thermoresponsive poly(N-isopropylacrylamide) copolymers: contact angles and surface energies of polymer films. Langmuir (2004) 0.86
Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere (2010) 0.85
Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm (2011) 0.85
Leave the policing to others. Nat Nanotechnol (2013) 0.85
Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale (2013) 0.85
Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett (2010) 0.85
Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells. Cardiovasc Pathol (2003) 0.84
Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol (2013) 0.84
Universality in lattice models of dynamic arrest: introduction of an order parameter. Phys Rev Lett (2002) 0.83
Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake. Small (2014) 0.83
Clarification of the bootstrap percolation paradox. Phys Rev Lett (2004) 0.83
Proteomic analysis of factors released from p21-overexpressing tumour cells. Proteomics (2006) 0.83
Stabilising fluorescent silica nanoparticles against dissolution effects for biological studies. Chem Commun (Camb) (2012) 0.83
Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles. Nanoscale (2013) 0.82
Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem Neurosci (2013) 0.82
Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier. ACS Nano (2014) 0.81
Surfactant titration of nanoparticle-protein corona. Anal Chem (2014) 0.81
Controlling aqueous silica nanoparticle synthesis in the 10-100 nm range. Chem Commun (Camb) (2015) 0.80
Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies. Biomaterials (2006) 0.80
The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation. Chembiochem (2013) 0.80
Nanomaterials: impact on cells and cell organelles. Adv Exp Med Biol (2014) 0.80